Loading...
Triple-S Management Corporation
GTS•NYSE
Healthcare
Medical - Healthcare Plans
$35.99
$0.37(1.04%)

Financial performance has remained strong, with revenue growing from $999.02M in Q4 2020 to $1.05B in Q3 2021. Gross profit continued to perform well, with margins at 100% in the latest quarter. Operating income reached $15.79M in Q3 2021, holding a steady 2% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $19.34M. Net income dropped to $8.17M, keeping EPS at $0.35. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan